SCULPTRA® (Box of 2 Vials / 2 x 5 mL) | Galderma

Short Description

The standard clinical multi-vial presentation of the pioneer Poly-L-Lactic Acid (PLLA) collagen biostimulator, containing two sterile vials (300 mg total active PLLA microparticles). Calibrated for bilateral full-face structural restoration, multi-planar vector lifting, or combined face-and-neck biostimulation, the 2-vial kit yields 16 to 18 mL of injectable suspension, providing practitioners with a complete, single-session treatment unit to trigger de novo Type I neocollagenesis lasting 24+ months.

Detailed Description

The SCULPTRA® 2-Vial Presentation (CE-marked European and international standard packaging) represents the primary clinical unit utilized by aesthetic physicians for global facial biorejuvenation. Because structural age-related volume loss and elastosis affect facial anatomy symmetrically across deep fat compartments, temporal hollows, and mandibular vectors, single-vial treatments frequently result in under-correction for mature patients. The 2-vial kit supplies the total bio-active load required to treat both facial halves comprehensively within a single session.

Each box contains two individually sealed, sterile glass vials containing:

• 150 mg of Poly-L-Lactic Acid (PLLA) microparticles (300 mg total per box)

• 90 mg of Sodium Carboxymethylcellulose (CMC) carrier (180 mg total per box)

• 127.5 mg of Non-pyrogenic Mannitol (255 mg total per box)

When reconstituted according to modern immediate-hydration protocols, each vial yields approximately 8.0 to 9.0 mL of homogeneous microparticle suspension (yielding 16.0 to 18.0 mL of total working volume per box). This dual-vial volume allows practitioners to address the entire kinetic facial framework—temples, submalar hollows, pre-auricular zones, and jawline borders—without compromising on product dispersion density or biostimulatory coverage.

Bilateral Facial Dosing & Anatomical Mapping (2-Vial Session)

A standard full-face session utilizing the 2-vial kit allocates 1 vial (8–9 mL) per facial side (Left vs. Right), ensuring balanced bilateral symmetry and homogeneous microparticle distribution:

Simultaneous Reconstitution Protocol (2-Vial Preparation)

To ensure clinical efficiency and particle homogeneity across both facial sides:

[Vial 1 (150 mg PLLA)] + 5.0 mL SWFI ──┐
                                       ├─► [Vigorous Shake 1 Min] ─► Stand 10 Min ─► + 1-2 mL 2% Lindo per vial
[Vial 2 (150 mg PLLA)] + 5.0 mL SWFI ──┘

1. Aseptic Access: Remove the flip-off caps from both vials and wipe the stoppers with 70% isopropyl alcohol.

2. SWFI Introduction: Using an 18G draw-up needle on a 10 mL syringe, introduce 5.0 mL of Sterile Water for Injection (SWFI) down the inner glass wall of each vial.

3. Agitation: Vigorously shake each vial manually for 60 seconds until the lyophilized cake is fully suspended and no dry powder clings to the base or walls.

4. Hydration Period: Allow both vials to rest undisturbed for 10 to 15 minutes to ensure complete polymer wetting.

5. Lidocaine Addition: Immediately prior to clinical injection, add 1.0 to 2.0 mL of 2% Lidocaine HCl (with or without epinephrine) to each vial. Gently swirl to mix.

6. Syringe Loading: Draw the reconstituted suspension into 1 mL or 3 mL Luer-Lock syringes immediately before injection to prevent particle settling. If particles settle in the syringe, invert or roll between palms before extrusion.

The Clinical “Decade Rule” Treatment Staging

In global aesthetic consensus guidelines, the recommended total number of Sculptra vials across an entire multi-session treatment cycle is estimated using the patient’s age:

• Patient in 40s (4 Vials Total):

  • Session 1: 1 Box (2 Vials) — bilateral full face

  • Session 2 (6 weeks later): 1 Box (2 Vials) — structural touch-up and vector reinforcement

• Patient in 50s (5 Vials Total):

  • Session 1: 1 Box (2 Vials) — structural foundation

  • Session 2 (6 weeks later): 1 Box (2 Vials) — lateral vector lifting and midface redensification

  • Session 3 (6 weeks later): 1 Single Vial — targeted perimeter refinement

• Patient in 60s+ (6 Vials Total):

  • Session 1: 1 Box (2 Vials)

  • Session 2 (6 weeks later): 1 Box (2 Vials)

  • Session 3 (6 weeks later): 1 Box (2 Vials)

Technical Specifications

Post-Procedure Care & Patient Compliance

Because two vials deliver 300 mg of solid microparticles across the face, strict mechanical dispersion is critical to prevent focal microparticle clumping:

• The 5-5-5 Rule: The patient must vigorously massage all treated facial sectors for 5 minutes, 5 times daily, for 5 consecutive days.

• Hydration & Sunscreen: Advise the patient to avoid direct UV exposure, tanning beds, and high-heat environments (saunas, steam baths) until all acute swelling and needle erythema subside.

• Delayed Response Expectation: Manage patient expectations by reinforcing that initial fluid fullness resolves within 48 to 72 hours; genuine structural collagen remodeling begins at week 3 and reaches peak clinical projection between months 3 and 6.

Professional Advisory: SCULPTRA® 2-Vial Kit is a prescription-only medical biostimulant intended strictly for certified dermatologists, plastic surgeons, and credentialed aesthetic physicians. Direct injection into the hyper-mobile vermilion lip body, the tear trough / lower eyelid boundary, or the superficial papillary dermis is strictly contraindicated due to the high risk of visible, fibrotic nodule formation.